311 related articles for article (PubMed ID: 34347881)
41. Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants.
Salerno SN; Edginton A; Gerhart JG; Laughon MM; Ambalavanan N; Sokol GM; Hornik CD; Stewart D; Mills M; Martz K; Gonzalez D;
Clin Pharmacol Ther; 2021 Jan; 109(1):253-262. PubMed ID: 32691891
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data.
Bergagnini-Kolev M; Kane K; Templeton IE; Curran AK
AAPS J; 2023 Jun; 25(4):62. PubMed ID: 37344751
[TBL] [Abstract][Full Text] [Related]
43. Physiologically-based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors.
Ueno T; Miyajima Y; Landry I; Lalovic B; Schuck E
CPT Pharmacometrics Syst Pharmacol; 2021 May; 10(5):455-466. PubMed ID: 33704920
[TBL] [Abstract][Full Text] [Related]
44. Use of Developmental Midazolam and 1-Hydroxymidazolam Data with Pediatric Physiologically Based Modeling to Assess Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyl Transferase 2B4 Ontogeny In Vivo.
Johnson TN; Howgate EM; de Wildt SN; Turner MA; Rowland Yeo K
Drug Metab Dispos; 2023 Aug; 51(8):1035-1045. PubMed ID: 37169511
[TBL] [Abstract][Full Text] [Related]
45. A case series evaluating patient perceptions after switching from nusinersen to risdiplam for spinal muscular atrophy.
Powell JC; Meiling JB; Cartwright MS
Muscle Nerve; 2024 Feb; 69(2):179-184. PubMed ID: 38040488
[TBL] [Abstract][Full Text] [Related]
46. First Oral Drug Approved for Spinal Muscular Atrophy.
Aschenbrenner DS
Am J Nurs; 2020 Dec; 120(12):22-23. PubMed ID: 33214367
[No Abstract] [Full Text] [Related]
47. Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes.
Tseng E; Eng H; Lin J; Cerny MA; Tess DA; Goosen TC; Obach RS
Drug Metab Dispos; 2021 Oct; 49(10):947-960. PubMed ID: 34326140
[TBL] [Abstract][Full Text] [Related]
48. Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
Prakash C; Fan B; Ke A; Le K; Yang H
Cancer Chemother Pharmacol; 2020 Nov; 86(5):619-632. PubMed ID: 32978634
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Cytochrome P450 3A4-Mediated Drug-Drug Interaction Potential for Cobimetinib Using Physiologically Based Pharmacokinetic Modeling and Simulation.
Budha NR; Ji T; Musib L; Eppler S; Dresser M; Chen Y; Jin JY
Clin Pharmacokinet; 2016 Nov; 55(11):1435-1445. PubMed ID: 27225997
[TBL] [Abstract][Full Text] [Related]
50. Recognition of single-stranded nucleic acids by small-molecule splicing modulators.
Tang Z; Akhter S; Ramprasad A; Wang X; Reibarkh M; Wang J; Aryal S; Thota SS; Zhao J; Douglas JT; Gao P; Holmstrom ED; Miao Y; Wang J
Nucleic Acids Res; 2021 Aug; 49(14):7870-7883. PubMed ID: 34283224
[TBL] [Abstract][Full Text] [Related]
51. Predictions of metabolic drug-drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamil.
Perdaems N; Blasco H; Vinson C; Chenel M; Whalley S; Cazade F; Bouzom F
Clin Pharmacokinet; 2010 Apr; 49(4):239-58. PubMed ID: 20214408
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approach.
Schaller S; Martins FS; Balazki P; Böhm S; Baumgart J; Hilger RA; Beelen DW; Hemmelmann C; Ring A
Br J Clin Pharmacol; 2022 Feb; 88(4):1722-1734. PubMed ID: 34519068
[TBL] [Abstract][Full Text] [Related]
53. Prediction of Drug-Drug Interactions with Crizotinib as the CYP3A Substrate Using a Physiologically Based Pharmacokinetic Model.
Yamazaki S; Johnson TR; Smith BJ
Drug Metab Dispos; 2015 Oct; 43(10):1417-29. PubMed ID: 26180127
[TBL] [Abstract][Full Text] [Related]
54. Advances in the Therapy of Spinal Muscular Atrophy.
Klotz J; Tesi Rocha C; Dunaway Young S; Duong T; Buu M; Sampson J; Day JW
J Pediatr; 2021 Sep; 236():13-20.e1. PubMed ID: 34197889
[No Abstract] [Full Text] [Related]
55. Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions.
Ono C; Hsyu PH; Abbas R; Loi CM; Yamazaki S
Drug Metab Dispos; 2017 Apr; 45(4):390-398. PubMed ID: 28167538
[TBL] [Abstract][Full Text] [Related]
56. Risdiplam in non-sitter patients aged 16 years and older with 5q spinal muscular atrophy.
Ñungo Garzón NC; Pitarch Castellano I; Sevilla T; Vázquez-Costa JF
Muscle Nerve; 2023 May; 67(5):407-411. PubMed ID: 36815750
[TBL] [Abstract][Full Text] [Related]
57. Characterization of Pediatric Rectal Absorption, Drug Disposition, and Sedation Level for Midazolam Gel Using Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.
Zhu J; Zhou S; Wang L; Zhao Y; Wang J; Zhao T; Li T; Shao F
Mol Pharm; 2024 May; 21(5):2187-2197. PubMed ID: 38551309
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta-analysis.
Pascual-Morena C; Martínez-Vizcaíno V; Cavero-Redondo I; Martínez-García I; Moreno-Herráiz N; Álvarez-Bueno C; Saz-Lara A
Pharmacotherapy; 2024 Jan; 44(1):97-105. PubMed ID: 37574770
[TBL] [Abstract][Full Text] [Related]
59. Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin.
Quinney SK; Zhang X; Lucksiri A; Gorski JC; Li L; Hall SD
Drug Metab Dispos; 2010 Feb; 38(2):241-8. PubMed ID: 19884323
[TBL] [Abstract][Full Text] [Related]
60. Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens.
Moj D; Hanke N; Britz H; Frechen S; Kanacher T; Wendl T; Haefeli WE; Lehr T
AAPS J; 2017 Jan; 19(1):298-312. PubMed ID: 27822600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
